Pharma 9220 SRL
0.3 FTEPharma 9220 reported total assets of 915,194 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026), with 0.3 full-time equivalent.
The score of Pharma 9220 shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma 9220's annual accounts
| 2025 | |
|---|---|
| Net result | 214,716 € |
| Equity | 497,987 € |
| Cash | 458,412 € |
| EBITDA | 291,352 € |
| Total assets | 915,194 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
Pharma 9220's financial analysis
- Solvency54.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma 9220
Pharma 9220's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1019.772.381
- VAT number
- BE1019772381
- Peppol
- Registered · 0208:1019772381 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Feb 2025
- Registered office
- 9220 Hamme (Vl.)
- Size
- Micro · 0.3 FTE
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma 9220 (SRL) has been based in Hamme (Vl.) since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 214,716 € and equity of 497,987 €; its revenue is not published. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 54.4%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma 9220
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Verslype Cosmopolite Retail sale of pharmaceutical products Knokke-Heist · balance sheet 915,091 €
- Propharma Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 915,541 €
- Pharmacie de Rudder Retail sale of pharmaceutical products Rixensart · balance sheet 915,736 €
- Holsbeek Deurne Retail sale of pharmaceutical products Antwerp · balance sheet 917,585 €
- COX Retail sale of pharmaceutical products Hasselt · balance sheet 917,941 €
- Yokriphar Retail sale of pharmaceutical products Tienen · balance sheet 919,785 €
- Pharmanema Retail sale of pharmaceutical products Leuven · balance sheet 910,021 €
- Maral Pharma Retail sale of pharmaceutical products Châtelet · balance sheet 920,622 €
Frequently asked questions about Pharma 9220
What is the revenue of Pharma 9220?
Pharma 9220 files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma 9220?
In Belgium, the VAT number is the company number prefixed with BE: BE1019772381 for Pharma 9220, if the company is VAT-registered. Its company number (CBE) is 1019.772.381.
Where is the registered office of Pharma 9220?
According to the CBE register, the registered office of Pharma 9220 is in 9220 Hamme (Vl.).
What is the equity of Pharma 9220?
At the close of the 2025 financial year, the equity of Pharma 9220 amounts to 497,987 €, a solvency of 54.4% of total assets.
How many people work at Pharma 9220?
0.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma 9220?
The register lists 2 active mandates at Pharma 9220. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma 9220
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →